EHRA 22: Early Rhythm Control Therapy For AF Patients Found To Reduce Cardiovascular Outcomes

Published: 06 Apr 2022

  • Views:

    Views Icon 375
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating
Download Transcript

In this short late-breaking interview, Dr Jason Andrade (Vancouver General / Montreal Heart Institute, Montreal, CA) joins us at EHRA 2022 to outline the findings of a meta-analysis of EAST-AFNET 4. The main outcomes suggest that early rhythm control therapy is beneficial for AF patients, reducing their cardiovascular outcomes.

Discussion points:

  1. Reasoning behind this meta-analysis
  2. Study design and patient population
  3. Key findings
  4. Take-home messages
  5. Further research required

Recorded on-site in Copenhagen, EHRA Conference 2022.
Interviewer: Jonathan McKenna
Editor: Jordan Rance